PETVIVO HOLDINGS, INC. ANOUNCES LAUNCH OF NEW COMPANY AND PRODUCT WEBSITES
07 mars 2022 07h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, March 07, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE WESTERN VETERINARY CONFERENCE IN LAS VEGAS, NEVADA
01 mars 2022 07h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, March 01, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
PetVivo Reports Third Quarter 2022 Financial Results
10 févr. 2022 16h00 HE
|
PetVivo Holdings, Inc.
Conference call begins at 4:00 p.m. Central time today EDINA, MN, Feb. 10, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the...
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THIRD QUARTER ENDED DECEMBER 31, 2021 [UPDATED]
03 févr. 2022 18h05 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Feb. 03, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical...
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THIRD QUARTER ENDED DECEMBER 31, 2021
03 févr. 2022 14h38 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Feb. 03, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical...
PETVIVO HOLDINGS, INC. LAUNCHES DIGITAL MEDIA CAMPAIGN
29 nov. 2021 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Nov. 29, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (“PetVivo”), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics...
PetVivo Reports Second Quarter 2022 Financial Results - Updated
15 nov. 2021 17h10 HE
|
PetVivo Holdings, Inc.
Raised approximately 11.25 million in connection with Initial Public Offering Rebranded Kush™ as Spryng™ and commenced sales of Spryng™ Conference call begins at 4:00 p.m. Central time today EDINA,...
PetVivo Reports Second Quarter 2022 Financial Results
15 nov. 2021 15h00 HE
|
PetVivo Holdings, Inc.
Raised approximately 11.25 million in connection with Initial Public Offering Rebranded Kush™ as Spryng™ and commenced sales of Spryng™ Conference call begins at 4:00 p.m. Central time...
PetVivo Holdings to Present at Emerging Growth Conference on September 29, 2021
24 sept. 2021 08h00 HE
|
PetVivo Holdings, Inc.
PetVivo Holdings, Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. ...
Josh Wilhelm Joins PetVivo Holdings, Inc. as the Director of Manufacturing
08 sept. 2021 08h00 HE
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Sept. 08, 2021 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV) (the "Company") an emerging biomedical device company focused on the commercialization of innovative...